FCHSD1 Activators are a class of compounds that influence the actin cytoskeleton and endocytosis, both of which are key areas of FCHSD1's involvement. Actin dynamics are crucial for various cellular processes, including cell shape, motility, and vesicle trafficking. Compounds like Phalloidin and Jasplakinolide promote the stability and polymerization of actin filaments, which could necessitate the increased activity of FCHSD1 to regulate the enhanced actin structures within the cell. Conversely, Latrunculin A and Cytochalasin D disrupt actin polymerization, increasingthe demand for FCHSD1's involvement to re-establish a functional cytoskeleton. The disruption or enhancement of actin dynamics by these compounds creates a cellular environment that indirectly requires the activation of FCHSD1 to maintain or restore cytoskeletal integrity.
In addition to actin-targeting compounds, inhibitors of proteins that regulate actin polymerization, such as CK-666 and Wiskostatin, which respectively target the Arp2/3 complex and N-WASP, could indirectly lead to an upregulation of FCHSD1 activity. This upregulation would be part of the cellular response to counterbalance the inhibited actin nucleation and ensure proper cytoskeletal organization. Similarly, compounds like Y-27632 and ML-7 target Rho-associated kinases and myosin light chain kinase, which are involved in the formation of actin stress fibers and cellular contractility. Inhibition of these pathways could signal a need for FCHSD1 to participate in alternative pathways for maintaining cytoskeletal structure and cell motility. Additionally, microtubule dynamics, influenced by Nocodazole, are interdependent with actin structures, and alterations in microtubule stability can indirectly necessitate the activation of FCHSD1 due to the closely linked regulation of the cytoskeleton.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
A bicyclic peptide that stabilizes F-actin and prevents its depolymerization. Stabilizing actin filaments can enhance FCHSD1 activity as it may be required to adapt to the increased cytoskeletal integrity and contribute to actin dynamics regulation. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
A cyclodepsipeptide that induces actin polymerization and stabilizes actin filaments. By promoting actin filament formation, it can indirectly increase FCHSD1's role in actin cytoskeleton reorganization. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
An actin polymerization inhibitor that sequesters actin monomers. The subsequent changes in actin dynamics may increase the need for FCHSD1-mediated regulation of actin cytoskeletal rearrangements. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
A disaccharide that severs actin filaments and caps their ends, preventing polymerization. This leads to a cellular response requiring FCHSD1 activity for re-establishing actin cytoskeleton organization. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor that blocks actin nucleation. This disruption in actin polymerization may enhance the activity of FCHSD1 as the cell seeks to maintain cytoskeletal stability. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
An N-WASP inhibitor that prevents actin nucleation by the Arp2/3 complex. Inhibiting N-WASP can lead to a compensatory rise in FCHSD1 activity to maintain cellular actin dynamics. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that may indirectly affect actin organization. The alteration of microtubule dynamics can influence actin structures and potentially enhance FCHSD1 function in actin cytoskeletal regulation. | ||||||